To gain a deeper understanding of the relevance and underlying mechanisms of the innate immune pathway in cholangiocarcinoma, we investigated the expression levels of DDX58, MAVS, C6orf150, TMEM173, IKBKE, TBK1, and IRF3 in different cell types using the TISCH2 database. This evidence concerns the gene STING1 and cholangiocarcinoma.